1. Home
  2. SPRC vs TSBX Comparison

SPRC vs TSBX Comparison

Compare SPRC & TSBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • TSBX
  • Stock Information
  • Founded
  • SPRC 2004
  • TSBX 2015
  • Country
  • SPRC Israel
  • TSBX United States
  • Employees
  • SPRC N/A
  • TSBX N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • TSBX
  • Sector
  • SPRC Health Care
  • TSBX
  • Exchange
  • SPRC Nasdaq
  • TSBX Nasdaq
  • Market Cap
  • SPRC 11.6M
  • TSBX 12.3M
  • IPO Year
  • SPRC N/A
  • TSBX 2023
  • Fundamental
  • Price
  • SPRC $0.60
  • TSBX $0.44
  • Analyst Decision
  • SPRC
  • TSBX Buy
  • Analyst Count
  • SPRC 0
  • TSBX 3
  • Target Price
  • SPRC N/A
  • TSBX $4.75
  • AVG Volume (30 Days)
  • SPRC 24.5M
  • TSBX 153.9K
  • Earning Date
  • SPRC 02-15-2025
  • TSBX 11-12-2024
  • Dividend Yield
  • SPRC N/A
  • TSBX N/A
  • EPS Growth
  • SPRC N/A
  • TSBX N/A
  • EPS
  • SPRC N/A
  • TSBX N/A
  • Revenue
  • SPRC $1,747,000.00
  • TSBX N/A
  • Revenue This Year
  • SPRC N/A
  • TSBX N/A
  • Revenue Next Year
  • SPRC N/A
  • TSBX N/A
  • P/E Ratio
  • SPRC N/A
  • TSBX N/A
  • Revenue Growth
  • SPRC N/A
  • TSBX N/A
  • 52 Week Low
  • SPRC $0.20
  • TSBX $0.40
  • 52 Week High
  • SPRC $6.78
  • TSBX $5.75
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 52.60
  • TSBX 40.57
  • Support Level
  • SPRC $0.63
  • TSBX $0.41
  • Resistance Level
  • SPRC $0.91
  • TSBX $0.62
  • Average True Range (ATR)
  • SPRC 0.22
  • TSBX 0.06
  • MACD
  • SPRC -0.00
  • TSBX -0.01
  • Stochastic Oscillator
  • SPRC 16.95
  • TSBX 14.15

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

Share on Social Networks: